"Faculty, students can’t take gifts from industry. New policy comes after consulting fee probe of ex-department head."-Atlanta Journal-Constitution
Emory University medical school tightens ethics-The Atlanta Journal-Constitution, 2009
There's a new policy at Emory University School of Medicine as a result of Senator Charles Grassley's investigation of consulting fees and the notorious Dr. Charles Nemeroff.
From the article:
"Emory University School of Medicine announced a toughened ethics policy Wednesday to better govern faculty and students in their financial dealings with outside industry.
Late last year, Emory became the focus of an ethics investigation by Congress and the National Institutes of Health. The NIH froze funds for a $9.3 million project.
Dr. Charles Nemeroff, the former chairman of Emory’s psychiatric and behavioral sciences department and an international expert on depression, was the central figure in the investigation. Congressional investigators said Nemeroff received $2.8 million in consulting fees from companies whose drugs he was evaluating and he failed to report a third of that amount to the university."
The new policy states that faculty and students cannot take gifts from industry.
From the article:
The school of medicine’s new ethics policy states that:
> Faculty, staff, students and trainees are prohibited from receiving any compensation, gifts or travel expenses from industry for speaking at industry promotional events.
> Faculty, staff, students and trainees are prohibited from accepting gifts from industry regardless of the amount. Industry gifts to the School of Medicine must be received through the School of Medicine Development Office.
> Industry representatives will have access to Emory buildings and personnel only by faculty invitation for necessary interactions. Sales and marketing representatives will be restricted from educational and training events and from patient areas.
> Faculty will disclose any financial relationships with industry in all formal lectures, and students and trainees may not be assigned to projects that are related to a faculty adviser’s conflict of interests.
Medical school spokeswoman Sarah Goodwin said a search will be conducted for a new psychiatry department head and the $9.3 million project has resumed. She said Nemeroff was no longer in charge."
~
My 2007 articles investigating and discussing Dr. Charles Nemeroff and his conflict of interests
My September 2007 article I wrote about Charles Nemeroff and full disclosure-soulful sepulcher blog
From my article: 2007
"This just begs for questioning ethics, honesty in data reporting, and a host of other thoughts when thinking about corrupt moral standards--yes I said corrupt moral standards--within the scientific community, pharmaceutical community, medical community, the FDA, doctors, lawyers, stock holders, you name it, it's all in the name of who? was it the patient? has someone lost sight somewhere along the way as to what the common goal was/is/should be and wasn't? the patient?
I declare war on ethics on my behalf. Period. I want and demand to see the raw data buried that ended up killing and crippling patients[kids!] on Paxil, and Zyprexa for starters."-Stephany
AND
My September 2007 article, "CME>Full Disclosure>Patent owner:Nemeroff and the Dalai Lama, part 3-soulful sepulcher blog
From my article: 2007
"By joining Emory's longstanding and groundbreaking research programs in depression and mood disorders with the highly successful programs at NIMH and the novel drug-development program at GlaxoSmithKline, we hope to better serve the millions of patients worldwide who suffer from these debilitating conditions," said Charles Nemeroff, Reunette W. Harris Professor and chair of psychiatry and behavioral sciences, who will serve as principal investigator of the new center. Clinton Kilts, professor of psychiatry and behavioral sciences and vice chair for research, will serve as associate director."
Thought Round Up: Link Up: Ghosts and truth 2007, soulful sepulcher blog
"Nemeroff keeps coming up where ever you read? read it ALL and you will want to flush your meds and run for the hills, if this is what we call Science and Medicine, and Psychiatry, then I want off of this Merry-Go-Round from hell right now. It's corrupt, full of lies and no one can be trusted. [this is my opinion,] but come on, read it all and wonder why it reads more like a horror story, because we are talking about patients in the end. YOU. and ME.
Read my ramble that includes links to what you need to understand, and note that Dr.Aubrey Blumsohn from Scientific Misconduct reminded me that I left out the entire "Ghost writers" and Ghost Science part. So in the end, what is left? what is science, I'm packing my bags, dumping my meds and heading for the Nemeroff and Dalai Lama conference. Anyone want to sponsor me?"-Stephany, 2007
~
Senator Grassley investigated where it was needed and now in 2009 the conflict of interest smack down at Emory begins with new ethic rules. Imagine that! Ethics!
Emory University medical school tightens ethics-The Atlanta Journal-Constitution, 2009
There's a new policy at Emory University School of Medicine as a result of Senator Charles Grassley's investigation of consulting fees and the notorious Dr. Charles Nemeroff.
From the article:
"Emory University School of Medicine announced a toughened ethics policy Wednesday to better govern faculty and students in their financial dealings with outside industry.
Late last year, Emory became the focus of an ethics investigation by Congress and the National Institutes of Health. The NIH froze funds for a $9.3 million project.
Dr. Charles Nemeroff, the former chairman of Emory’s psychiatric and behavioral sciences department and an international expert on depression, was the central figure in the investigation. Congressional investigators said Nemeroff received $2.8 million in consulting fees from companies whose drugs he was evaluating and he failed to report a third of that amount to the university."
The new policy states that faculty and students cannot take gifts from industry.
From the article:
The school of medicine’s new ethics policy states that:
> Faculty, staff, students and trainees are prohibited from receiving any compensation, gifts or travel expenses from industry for speaking at industry promotional events.
> Faculty, staff, students and trainees are prohibited from accepting gifts from industry regardless of the amount. Industry gifts to the School of Medicine must be received through the School of Medicine Development Office.
> Industry representatives will have access to Emory buildings and personnel only by faculty invitation for necessary interactions. Sales and marketing representatives will be restricted from educational and training events and from patient areas.
> Faculty will disclose any financial relationships with industry in all formal lectures, and students and trainees may not be assigned to projects that are related to a faculty adviser’s conflict of interests.
Medical school spokeswoman Sarah Goodwin said a search will be conducted for a new psychiatry department head and the $9.3 million project has resumed. She said Nemeroff was no longer in charge."
~
My 2007 articles investigating and discussing Dr. Charles Nemeroff and his conflict of interests
My September 2007 article I wrote about Charles Nemeroff and full disclosure-soulful sepulcher blog
From my article: 2007
"This just begs for questioning ethics, honesty in data reporting, and a host of other thoughts when thinking about corrupt moral standards--yes I said corrupt moral standards--within the scientific community, pharmaceutical community, medical community, the FDA, doctors, lawyers, stock holders, you name it, it's all in the name of who? was it the patient? has someone lost sight somewhere along the way as to what the common goal was/is/should be and wasn't? the patient?
I declare war on ethics on my behalf. Period. I want and demand to see the raw data buried that ended up killing and crippling patients[kids!] on Paxil, and Zyprexa for starters."-Stephany
AND
My September 2007 article, "CME>Full Disclosure>Patent owner:Nemeroff and the Dalai Lama, part 3-soulful sepulcher blog
From my article: 2007
"By joining Emory's longstanding and groundbreaking research programs in depression and mood disorders with the highly successful programs at NIMH and the novel drug-development program at GlaxoSmithKline, we hope to better serve the millions of patients worldwide who suffer from these debilitating conditions," said Charles Nemeroff, Reunette W. Harris Professor and chair of psychiatry and behavioral sciences, who will serve as principal investigator of the new center. Clinton Kilts, professor of psychiatry and behavioral sciences and vice chair for research, will serve as associate director."
Thought Round Up: Link Up: Ghosts and truth 2007, soulful sepulcher blog
"Nemeroff keeps coming up where ever you read? read it ALL and you will want to flush your meds and run for the hills, if this is what we call Science and Medicine, and Psychiatry, then I want off of this Merry-Go-Round from hell right now. It's corrupt, full of lies and no one can be trusted. [this is my opinion,] but come on, read it all and wonder why it reads more like a horror story, because we are talking about patients in the end. YOU. and ME.
Read my ramble that includes links to what you need to understand, and note that Dr.Aubrey Blumsohn from Scientific Misconduct reminded me that I left out the entire "Ghost writers" and Ghost Science part. So in the end, what is left? what is science, I'm packing my bags, dumping my meds and heading for the Nemeroff and Dalai Lama conference. Anyone want to sponsor me?"-Stephany, 2007
~
Senator Grassley investigated where it was needed and now in 2009 the conflict of interest smack down at Emory begins with new ethic rules. Imagine that! Ethics!
Posts
1 comments:
Hi Stephany!
I'm here. I believe that soon Emory will be knocking at your door.
:)
Love you!
Ana
Post a Comment